Global Cervical Cancer Diagnostic Tests Market 2014-2018

Global Cervical Cancer Diagnostic Tests Market 2014-2018

Category : Diagnostic and Biotech
Published On : December  2014
Pages : 103



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Paradigm
06.1 Epidemiology
06.2 Causes of Cervical Cancer
06.3 Diagnosis of Cervical Cancer
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Type of Test
08.1 Pap Smear Test
08.1.1 Conventional Pap
08.1.2 Liquid-based cytology
08.2 HPV Testing
08.3 Colposcopy
08.4 Cervical Cancer Biopsy
08.4.1 LEEP
08.4.2 ECC
08.4.3 Cone Biopsy
08.5 Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test
08.6 Global HPV Testing Market
08.6.1 Market Size and Forecast
08.7 Global Colposcopy Market
08.7.1 Market Size and Forecast
08.8 Global Pap Smear Test Market
08.8.1 Market Size and Forecast
08.9 Global Cervical Cancer Biopsy Market
08.9.1 Market Size and Forecast
09. Market Segmentation by Technology
09.1 ELISA
09.2 FISH
09.3 NASBA
09.4 PCR
09.5 Multichromatic Staining and Microscopy
09.6 Optical Imaging
10. Market Segmentation by Method
10.1 Molecular Method
10.2 Cytopathological Method
10.3 Physical Method
11. Geographical Segmentation
11.1 Geographical Segmentation of Global Cervical Cancer Diagnostic Tests Market
11.2 Cervical Cancer Diagnostic Tests Market in Americas
11.2.1 Market Size and Forecast
11.3 Cervical Cancer Diagnostic Tests Market in EMEA Region
11.3.1 Market Size and Forecast
11.4 Cervical Cancer Diagnostic Tests Market in APAC Region
11.4.1 Market Size and Forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Abbott Laboratories
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation by Revenue
20.1.4 Business Segmentation by Revenue 2011 and 2012
20.1.5 Geographical Segmentation by Revenue
20.1.6 Business Strategy
20.1.7 Key Information
20.1.8 SWOT Analysis
20.2 Becton, Dickinson and Co.
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Revenue Segmentation by Business
20.2.5 Segmental Revenue Comparison - 2013 and 2012
20.2.6 Revenue Segmentation by Geography
20.2.7 Business Strategy
20.2.8 Key Developments
20.2.9 SWOT Analysis
20.3 Hologic Inc.
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue 2013
20.3.4 Business Segmentation by Revenue 2012 and 2013
20.3.5 Sales by Geography
20.3.6 Business Strategy
20.3.7 Key Developments
20.3.8 SWOT Analysis
20.4 Qiagen
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Product Segmentation by Revenue 2013
20.4.4 Product Segmentation by Revenue 2012 and 2013
20.4.5 Geographical Segmentation by Revenue 2013
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis
20.5 Quest Diagnostics
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Business Segmentation by Revenue 2013
20.5.4 Business Segmentation by Revenue 2011-2013
20.5.5 Geographical Segmentation by Revenue 2013
20.5.6 Business Strategy
20.5.7 Recent Developments
20.5.8 SWOT Analysis
20.6 Roche Diagnostics
20.6.1 Key Facts
20.6.2 Business Overview
20.6.3 Business Segmentation by Revenue 2013
20.6.4 Geographical Segmentation by Revenue 2013
20.6.5 Business Strategy
20.6.6 Recent Developments
21. Other Reports in this Series


List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Incidence of Cervical Cancer (2013-2018)
Exhibit 3: Global Cervical Cancer Diagnostic Tests Market 2013-2018 (US$ million)
Exhibit 4: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test
Exhibit 5: Segmentation of Cervical Cancer Diagnostic Test Products by Type of Test
Exhibit 6: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test 2013-2018 (US$ million)
Exhibit 7: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test 2013-2018
Exhibit 8: Global HPV Testing Market 2013-2018 (US$ million)
Exhibit 9: Global Colposcopy Market 2013-2018 (US$ million)
Exhibit 10: Global Pap Smear Test Market 2013-2018 (US$ million)
Exhibit 11: Global Cervical Cancer Biopsy Market 2013-2018 (US$ million)
Exhibit 12: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Technology
Exhibit 13: Cervical Cancer Diagnostic Test Products Segmented by Technology
Exhibit 14: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Method
Exhibit 15: List of Tests Segmented Based on Methods used in Cervical Cancer Diagnostic Tests
Exhibit 16: Geographical Segmentation of Global Cervical Cancer Diagnostic Tests Market 2013-2018 (US$ million)
Exhibit 17: Global Cervical Cancer Diagnostic Tests Market by Geographical Segmentation 2013-2018
Exhibit 18: Cervical Cancer Diagnostic Tests Market in Americas 2013-2018 (US$ million)
Exhibit 19: Cervical Cancer Diagnostic Tests Market in EMEA Region 2013-2018 (US$ million)
Exhibit 20: Cervical Cancer Diagnostic Tests Market in APAC Region 2013-2018 (US$ million)
Exhibit 21: Advantages and Limitations of Various Diagnostic Platforms
Exhibit 22: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 23: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 24: Product Categorization of Becton, Dickinson and Co.
Exhibit 25: Revenue Segmentation of Becton, Dickinson and Co. 2013
Exhibit 26: Revenue Comparison (US$ million)
Exhibit 27: Revenue Segmentation of Becton, Dickinson and Co. by Geography 2013
Exhibit 28: Revenue Segmentation of Hologic Inc. 2013
Exhibit 29: Revenue Comparison FY2012 and FY2013 (US$ million)
Exhibit 30: Hologic Inc.: Sales by Geography 2013
Exhibit 31: Qiagen: Product Segmentation by Revenue 2013
Exhibit 32: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 33: Qiagen: Geographical Segmentation by Revenue 2013
Exhibit 34: Quest Diagnostics: Business Segmentation by Revenue 2013
Exhibit 35: Quest Diagnostics: Business Segmentation by Revenue 2011-2013 (US$ billion)
Exhibit 36: Quest Diagnostics: Geographical Segmentation by Revenue 2013
Exhibit 37: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 38: Roche Diagnostics: Geographical Segmentation by Revenue 2013



Enquiry Before Buy